In summary, asymptomatic patients had higher anti-SARS-CoV-2 spike IFN-γ secreting cells than the symptomatic clinical phenotypes at the time of COVID-19 diagnosis, suggesting a possible protective role. This evidence concerns the gene IFNG and COVID-19.